The ratio of IgG/IgM and IgG/IgA in colon cancer patients was significantly lower compared with controls [93], and similar data were obtained for breast cancer patients, including those with the early stages of the disease in both cancer types [92]. The gene discussed is CD40LG; the disease is cancer.